Cargando…
Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass
Aging reduces the number of mesenchymal stem cells (MSCs) in the bone marrow which leads to impairment of osteogenesis. However, if MSCs could be directed toward osteogenic differentiation, they could be a viable therapeutic option for bone regeneration. We have developed a method to direct the MSCs...
Autores principales: | Guan, Min, Yao, Wei, Liu, Ruiwu, Lam, Kit S., Nolta, Jan, Jia, Junjing, Panganiban, Brian, Meng, Liping, Zhou, Ping, Shahnazari, Mohammad, Ritchie, Robert O., Lane, Nancy E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755884/ https://www.ncbi.nlm.nih.gov/pubmed/22306732 http://dx.doi.org/10.1038/nm.2665 |
Ejemplares similares
-
A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation
por: Jiang, Min, et al.
Publicado: (2020) -
Differential Maintenance of Cortical and Cancellous Bone Strength Following Discontinuation of Bone-Active Agents
por: Shahnazari, Mohammad, et al.
Publicado: (2011) -
Identification of osteogenic progenitor cell-targeted peptides that augment bone formation
por: Jiang, Min, et al.
Publicado: (2020) -
Inhibition of the Progesterone Nuclear Receptor during the Bone Linear Growth Phase Increases Peak Bone Mass in Female Mice
por: Yao, Wei, et al.
Publicado: (2010) -
Overexpression of Secreted Frizzled-Related Protein 1 Inhibits Bone Formation and Attenuates Parathyroid Hormone Bone Anabolic Effects
por: Yao, Wei, et al.
Publicado: (2010)